These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33751617)

  • 41. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
    Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
    Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perfusion computed tomography to assist decision making for stroke thrombolysis.
    Bivard A; Levi C; Krishnamurthy V; McElduff P; Miteff F; Spratt NJ; Bateman G; Donnan G; Davis S; Parsons M
    Brain; 2015 Jul; 138(Pt 7):1919-31. PubMed ID: 25808369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy.
    Evans NR; Sibson L; Day DJ; Agarwal S; Shekhar R; Warburton EA
    BMJ Open; 2022 Jan; 12(1):e057372. PubMed ID: 35039306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of thrombolysis in lacunar stroke - evidence from the Austrian Stroke Unit Registry.
    Eggers CCJ; Bocksrucker C; Seyfang L;
    Eur J Neurol; 2017 Jun; 24(6):780-787. PubMed ID: 28449276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
    Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
    BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
    Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
    Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
    Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
    Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study.
    Kunz A; Ebinger M; Geisler F; Rozanski M; Waldschmidt C; Weber JE; Wendt M; Winter B; Zieschang K; Fiebach JB; Villringer K; Erdur H; Scheitz JF; Tütüncü S; Bollweg K; Grittner U; Kaczmarek S; Endres M; Nolte CH; Audebert HJ
    Lancet Neurol; 2016 Sep; 15(10):1035-43. PubMed ID: 27430529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efforts to reduce the door-to-needle time of thrombolysis in acute ischemic stroke: video-assisted therapeutic risk communication.
    Hsieh CY; Chen WF; Chen CH; Wang CY; Chen CJ; Lai EC; Chen TS
    J Formos Med Assoc; 2014 Dec; 113(12):929-33. PubMed ID: 24412584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The First 10 Thrombolysis for Acute Ischemic Stroke in Lao People's Democratic Republic under Teleconsultation from Thailand.
    Chutinet A; Keosodsay S; Vorasayan P; Samajarn J; Akarathanawat W; Kijpaisalratana N; Norsakpeseuth N; Phetsiriseng K; Thongsna S; Vongvasinkul P; Suwanwela NC
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104327. PubMed ID: 31530479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department.
    Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R
    Med J Aust; 2007 Nov; 187(10):567-70. PubMed ID: 18021045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prehospital and Emergency Department-Focused Mission Protocol Improves Thrombolysis Metrics for Suspected Acute Stroke Patients.
    Madhok DY; Keenan KJ; Cole SB; Martin C; Hemphill JC
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104423. PubMed ID: 31606319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.
    Sablot D; Ion I; Khlifa K; Farouil G; Leibinger F; Gaillard N; Laverdure A; Bensalah ZM; Mas J; Fadat B; Smadja P; Ferraro-Allou A; Bonnec JM; Olivier N; Dutray A; Tardieu M; Dumitrana A; Guibal A; Jurici S; Bertrand JL; Allou T; Arquizan C; Bonafe A
    Cerebrovasc Dis; 2018; 45(5-6):245-251. PubMed ID: 29843148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.